Twyman et al. 25 gained a radioresistant cell line from tumor relapsed after radiation and anti-CTLA4 treatment, and resistance was confirmed in vivo but had similar clonogenic survival in vitro. This evidence concerns the gene CTLA4 and neoplasm.